Effective Assessment of Response to Therapy in Patients with MDS

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: October 17, 2014
Expiration Date: October 17, 2015

Expected time to complete this activity as designed: 15 minutes
There are no fees for participating in or receiving credit for this online activity.

Program Overview

Myelodysplastic syndromes, or MDS, have progressed in recent years from a disease with few treatments other than supportive care, to one with a natural history and several treatment options. The ongoing challenge with MDS, however, is that this disease can be a predisposition state for acute myelogenous leukemia, and clinicians therefore must be vigilant about appropriately treating and monitoring their MDS patients to minimize the potential for the patient to develop leukemia. In this focused interview, Dr. Stephen Nimer discusses critical elements that must be considered when patient response to treatment is being assessed, and the therapeutic choices that clinicians face based on the results of these assessments.

Target Audience

This activity is designed for physicians, pharmacists, physician assistants, and other health care professionals who have an interest in enhancing their clinical skills in treating patients with myelodysplastic syndrome.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Identify current and emerging treatment strategies and approaches to assessing response to therapy in patients with MDS

Agenda

Effective Assessment of Response to Therapy in Patients with MDS – Stephen D. Nimer, MD

Instructions for Participation and Credit

This activity is eligible for CME credit through October 17, 2015. After this date, this activity will expire and no further credit will be awarded.

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
  3. Complete the educational content as designed.
  4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
  5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
  6. Certificates for CME credit may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.

Faculty Biography

Stephen D. Nimer, MD
Director
Sylvester Comprehensive Cancer Center
University of Miami
Miami, Florida

Dr. Stephen Nimer received his medical degree with honors from the University of Chicago of Medicine. He completed training in internal medicine and hematology/oncology at the UCLA School of Medicine. A hematologist, molecular biologist, and bone marrow transplant physician, Dr. Nimer is currently the director of the Sylvester Comprehensive Cancer Center at the University of Miami, Florida.

Dr. Nimer was at Memorial Sloan-Kettering Cancer Center in New York for nearly 20 years, where he held the Alfred P. Sloan chair and served as head of the Division of Hematologic Oncology, was vice chairman for faculty development, and chief of the hematology service. He also served as a member of Sloan-Kettering Institute for Cancer Research, was an attending physician at Memorial Hospital, and a professor of medicine and pharmacology at Weill Medical College of Cornell University.

Dr. Nimer was elected to the American Society of Clinical Investigators, and is a fellow of the American College of Physicians. He serves on the editorial board of several medical journals, and is on the medical boards of the Myelodysplastic Syndrome Foundation, the Bone Marrow Foundation, and others. Dr. Nimer is also the chairman of the medical advisory board of Gabrielle's Angel Foundation for Cancer Research.

Over the years, Dr. Nimer has conducted extensive clinical and basic science research into the treatment and genetic basis of adult leukemia and bone marrow failure states, defining the regulatory mechanisms that control the production of blood cells and exploring ways to improve the treatment of blood based cancers. He has authored over 200 scientific publications and has received numerous awards for his research, including the prestigious Irma T. Hirschl Career Scientist Award.

Accreditation

MediCom CME CREDIT
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACPE CPE CREDIT
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for .25 contact hours of Continuing Education Credit. Universal Activity Number: 827-0000-14-029-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when registering for a CPE program. Please make sure to provide this information in your Member Profile accessed through the Member Center on the home page of this site.

Disclosure

As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Dr. Stephen Nimer has disclosed no relevant financial relationships.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, and Eugene R. Tombler, PhD, FACME, medical director, oncology, have no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is independently peer reviewed for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

Off-Label Disclosures/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Dr. Nimer has indicated that he does not intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Dr. Nimer has indicated that he does not intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.

Hardware/Software/Internet Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player, and/or Microsoft® Silverlight™.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at info@managingmds.com.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation.

©2014 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Managing MDS would like to recognize and thank Celgene Corporation for their educational support of ManagingMDS.com

©2017 MediCom Worldwide, Inc. All rights reserved